All authors are with the Department of Health Sciences, California State University East Bay, Hayward.
Am J Public Health. 2020 Jun;110(6):807-810. doi: 10.2105/AJPH.2020.305628. Epub 2020 Apr 16.
Stigma plays an important role in understanding successful interventions to control the opioid epidemic in the United States. Stigma has been described both as an agent to incentivize positive health behavior and as an agent of marginalization contributing to poorer health. Past scholarship has argued that stigma has positively motivated public health changes, for example, among tobacco users; it has also been associated with discrimination against vulnerable individuals, resulting in increasingly poorer health behaviors, for example in relation to HIV-prevention messaging.The discourse on stigma may conflate the denormalization of unhealthy behaviors with wholesale rejection of individual identities. More effective interventions would counter stigma against people who use opioids in general and specifically denormalize opioid misuse. These interventions might alter the effect of public health messaging and ultimately improve outcomes.We argue that public health educators and communication campaigns can contribute to positive social norm change and motivate healthy behaviors by incorporating strategies that attempt to disentangle unhealthy behaviors from identity.
污名化在理解美国控制阿片类药物泛滥的成功干预措施方面起着重要作用。污名化既被描述为激励积极健康行为的因素,也被描述为导致健康状况恶化的边缘化因素。过去的学术研究认为,污名化已经积极地推动了公共卫生的变革,例如在烟草使用者中;它也与针对弱势群体的歧视有关,导致越来越多的不健康行为,例如与 HIV 预防信息相关。关于污名化的讨论可能将不健康行为的去正常化与对个人身份的全盘否定混为一谈。更有效的干预措施将针对一般使用阿片类药物的人群的污名化,并特别将阿片类药物滥用去正常化。这些干预措施可能会改变公共卫生信息的效果,并最终改善结果。我们认为,公共卫生教育工作者和宣传活动可以通过采用试图将不健康行为与身份区分开来的策略,为积极的社会规范改变做出贡献,并激励健康行为。